SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$13.66−1.20 (-8.08%)
Close on Nov 20, 2026Market cap $2.76BP/E –Yield –
SELLAS Life Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
SELLAS Life Sciences's revenue for the twelve months ending Dec 31, 2023 was $0, down 100.0% year over year. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $9.32M in fiscal 2014.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $1.00M | -86.8% |
| FY2021 | Dec 31, 2021 | $7.60M | +300.0% |
| FY2020 | Dec 31, 2020 | $1.90M | – |
| FY2019 | Dec 31, 2019 | $0 | -100.0% |
| FY2014 | Dec 31, 2014 | $9.32M | +274.7% |
| FY2013 | Dec 31, 2013 | $2.49M | – |
| FY2012 | Dec 31, 2012 | $0 | – |
| FY2011 | Dec 31, 2011 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | $0 | -100.0% |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $1.00M | -82.5% |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021 | Jun 30, 2021 | $1.90M | – |
| Q1 FY2021 | Mar 31, 2021 | $5.70M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.90M | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | – |
See a number that looks wrong?